EXABLOK 30mg x 30 film coat tabl
Exablok is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NAF) with one or more risk factors such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischemic attack (TIA). Exablok is indicated for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE) and for the prevention of recurrent DVT and PE in adults (see section 4.4 for haemodynamically unstable patients with PE).
Exablok 30 mg film-coated tablets. Each film-coated tablet contains edoxaban tosilate monohydrate, equivalent to 30 mg edoxaban. Excipient with known effect. Each film-coated tablet contains 127.39 mg lactose (as monohydrate):
